fda bpc-157 category 2 compounding Legal Status: Regulations and bpc-157 safety concerns fda fda
Description
Patience and consistent technique carry you through
WADA only prohibits a few specific peptides that are, or have the potential to be, performance enhancing (listed above)
By directly infusing NAD+ into the bloodstream, the therapy bypasses the digestive system, allowing for better absorption and utilization of the molecule
Long-term human safety data does not exist, which is the main caution
